Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Turmeric may improve knee osteoarthritis, depression, and metabolic syndrome, but evidence is weak.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Platelet-rich plasma may help with wound healing, hair growth, and skin rejuvenation, but more research is needed to prove its effectiveness.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

Exosomes show promise for promoting hair growth and treating scalp disorders.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Hirsutism treatment should focus more on patient needs and quality of life.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.

PRP effectively treats hair loss, especially when combined with microneedling or minoxidil.

Collider bias can distort our understanding of COVID-19 risk and severity.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Public health decisions should rely on independent trials, not biased literature.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Large databases in research can lead to misleading conclusions due to biases and chance findings; researchers should analyze data more rigorously.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Reviewers criticized the study for assuming drugs with similar side-effects work the same way and questioned the validity of its findings due to potential biases and data quality issues.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

The peer review highlighted the need for clearer data handling, questioned the study's validity, and recognized improvements from the original version.

Reviewers criticized the study for its assumptions, social media data collection issues, and lack of comparison to existing methods.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.